EconomyLittle-known biotech’s cancer-drug gamble pays off as shares double
A string of successful cancer drug trial results has helped Genmab’s shares double in three months and bolstered its effort to own more of the medicines it develops.
C
CNBC★★☆☆☆2026-11-03 09:35Original
Little-known biotech’s cancer-drug gamble pays off as shares double
Economy